GSK plc

NYSE:GSK Stock Report

Market Cap: US$70.6b

GSK Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSE:GSK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Sep 24BuyUS$31,702Vishal SikkaIndividual773US$41.01
23 Sep 24BuyUS$9,187Hal BarronIndividual224US$41.01
23 Sep 24BuyUS$9,187Harry DietzIndividual224US$41.01
23 Sep 24BuyUS$9,187Anne BealIndividual224US$41.01
23 Sep 24BuyUS$73,862Charles BancroftIndividual1,801US$41.01
23 Sep 24BuyUS$9,187Tsun-Huei LeeIndividual224US$41.01
23 Sep 24BuyUS$9,146Elizabeth AndersonIndividual223US$41.01
23 Sep 24BuyUS$9,187Jesse GoodmanIndividual224US$41.01
20 Jun 24BuyUS$48,062Vishal SikkaIndividual1,179US$40.76
20 Jun 24BuyUS$9,131Hal BarronIndividual224US$40.76
20 Jun 24BuyUS$9,172Harry DietzIndividual225US$40.76
20 Jun 24BuyUS$9,172Anne BealIndividual225US$40.76
20 Jun 24BuyUS$73,825Charles BancroftIndividual1,811US$40.76
20 Jun 24BuyUS$9,172Elizabeth AndersonIndividual225US$40.76
20 Jun 24BuyUS$9,172Jesse GoodmanIndividual225US$40.76
20 Dec 23BuyUS$26,619Vishal SikkaIndividual727US$36.62
20 Dec 23BuyUS$8,348Hal BarronIndividual228US$36.62
20 Dec 23BuyUS$8,312Harry DietzIndividual227US$36.62
20 Dec 23BuyUS$8,312Anne BealIndividual227US$36.62
20 Dec 23BuyUS$64,333Charles BancroftIndividual1,757US$36.62
20 Dec 23BuyUS$8,348Elizabeth AndersonIndividual228US$36.62
20 Dec 23BuyUS$8,312Jesse GoodmanIndividual227US$36.62

Insider Trading Volume

Insider Buying: GSK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GSK?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,520,2540.0373%
Individual Insiders3,469,3610.085%
State or Government6,717,4270.165%
Private Companies45,842,1421.12%
Employee Share Scheme72,477,7821.78%
General Public467,033,27011.4%
Institutions3,483,439,46585.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 50.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.13%
Dodge & Cox
372,510,492US$6.4b-0.9%2.06%
8.48%
BlackRock, Inc.
346,116,839US$6.0b1.71%0.1%
4.7%
The Vanguard Group, Inc.
191,755,207US$3.3b0.53%0.05%
2.24%
State Street Global Advisors, Inc.
91,492,561US$1.6b1.22%0.06%
2.09%
Wellington Management Group LLP
85,113,207US$1.5b20.1%0.22%
2.05%
FMR LLC
83,733,483US$1.4b-3.52%0.08%
1.98%
Legal & General Investment Management Limited
80,832,617US$1.4b-3.73%0.26%
1.98%
Schroder Investment Management Limited
80,779,184US$1.4b17.1%0.9%
1.9%
Norges Bank Investment Management
77,390,644US$1.3b-10.1%0.11%
1.78%
GlaxoSmithKline Employee Trust
72,477,782US$1.3b-1.2%no data
1.63%
UBS Asset Management AG
66,697,894US$1.2b8.32%0.12%
1.24%
Mondrian Investment Partners Limited
50,764,058US$878.7m12%5.84%
1.2%
Silchester International Investors LLP
49,126,050US$850.3m-2.54%3.28%
1.12%
GlaxoSmithKline plc, Shareview Client
45,842,142US$793.5m-1.97%no data
1.07%
HSBC Global Asset Management (UK) Limited
43,586,855US$754.4m-3.5%0.31%
1.01%
Royal Bank of Canada Trust Company (Bahamas) Limited, Asset Management Arm
41,053,198US$710.6m-1.91%19.14%
0.95%
Fisher Asset Management, LLC
38,829,470US$672.1m0.18%0.28%
0.88%
Aviva Investors Global Services Ltd.
35,767,094US$619.1m-11.8%0.8%
0.82%
Columbia Management Investment Advisers, LLC
33,581,146US$581.3m-15.5%0.13%
0.78%
Royal London Asset Management Ltd.
31,962,532US$553.2m8.73%0.71%
0.74%
Strategic Advisers LLC
30,262,910US$523.8m-0.18%0.21%
0.73%
PRIMECAP Management Company
29,707,510US$514.2m2.36%0.37%
0.73%
Causeway Capital Management LLC
29,646,365US$513.1m8.55%2.22%
0.72%
Franklin Resources, Inc.
29,376,809US$508.5m-2.6%0.18%
0.72%
BNY Asset Management
29,268,752US$506.6m26.6%0.09%